HCP Live

HCPLive® is a detailed online platform that offers the latest clinical news and information tailored for healthcare professionals. It aims to equip physicians with valuable specialty and disease-specific resources to enhance patient care. At HCPLive®, users can access breaking news, insightful video interviews with medical experts, extensive coverage of medical conferences, updates on finance and practice management, as well as thoughtful commentary and analysis from physician writers, among other resources. Physicians Money Digest (PMD) serves as a reliable online financial guide for doctors, addressing various topics such as personal finance, investment strategies, retirement planning, practice management, and lifestyle choices. PMD features daily updates, expert advice, and articles penned by both current and former doctors, financial professionals, and healthcare journalists.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#331001

United States

#117492

Health/Medicine

#993

Traffic sources

Monthly visitors

Articles

Conference Preview: American Thoracic Society 2025

2 days ago | hcplive.com | Abigail Brooks

The American Thoracic Society’s (ATS) International Conference kicks off in San Francisco, California, on Sunday, May 18, 2025. Coined as the home of pulmonary, critical care, and sleep professionals, the 4-day conference will feature the latest advances in each of these spaces and boasts more than 10,000 attendees from 85 countries. The agenda for this year’s meeting will provide updates on key topics in asthma, COPD, lung cancer, sepsis, acute respiratory distress, sleep apnea, and more.
Systemic Symptoms of PR-10-Related Pollen Food Allergy Syndrome High in Pediatric Patients Surveyed

3 days ago | hcplive.com | Victoria Johnson

New research has highlighted the prevalence of systemic symptoms associated with PR-10 pollen food allergy syndrome (PFAS) in pediatric patients.1PFAS is generally recognized as a mild condition associated with oral allergy syndrome (OAS), but it is increasingly understood to be a condition that can cause systemic symptoms.
IgE, Skin Prick Test Show Limited Diagnostic Utility for Pediatric Shrimp Allergy

3 days ago | hcplive.com | Abigail Brooks

New research is shedding light on the diagnostic utility of IgE and skin prick test (SPT) for identifying shrimp allergy in pediatric patients.1Findings revealed SPT showed limited symptom correlation, whereas shrimp-specific IgE demonstrated greater diagnostic value than tropomyosin-specific IgE.
Diabetes Dialogue: Tirzepatide vs Semaglutide for Obesity, Understanding SURMOUNT-5

3 days ago | hcplive.com | Diana Isaacs |Natalie Bellini

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!Full results from the SURMOUNT-5 trial show tirzepatide (Zepbound) led to significantly greater weight loss than semaglutide 2.4 mg (Wegovy) in adults with obesity, according to findings published in The New England Journal of Medicine and presented at the 32nd European Congress on Obesity.
COVID-19 Vaccination Protects Against New-Onset, Post-Infection Fibromyalgia

5 days ago | hcplive.com | Victoria Johnson

Author(s):Fact checked by: COVID-19 vaccination is associated with a reduced risk of new-onset fibromyalgia in COVID-19 survivors, as shown by Kaplan–Meier survival analysis. Subgroup analyses reveal protective effects of vaccination against FM in males, individuals with BMI <30, and those with depression or anxiety.
Exfruxifermin Misses Primary Endpoint in Phase 2b Compensated MASH Cirrhosis Trial

5 days ago | hcplive.com | Abigail Brooks

Efruxifermin, bivalent fibroblast growth factor 21 (FGF21) analogue being developed for the treatment of metabolic dysfunction–associated steatohepatitis (MASH), failed to significantly reduce fibrosis without worsening of MASH at 36 weeks in a phase 2b trial.1 Data from the SYMMETRY trial were published in the New England Journal of Medicine and show that although the trial missed its primary endpoint for fibrosis reduction without worsening of MASH, the 50 mg dose of efruxifermin may have...
Global Rates of Gout Rising in Young Adults

5 days ago | hcplive.com | Victoria Johnson

Rates of adolescent gout are increasing worldwide, representing an escalating global health issue, and early intervention is needed to reduce disease burden, according to a new study.1“Gout increasingly affects adolescents. However, comprehensive data on adolescent gout are scarce.
SAGA Trial Results for Gildeuretinol Treating Geographic Atrophy with David Boyer, MD

6 days ago | hcplive.com | David Boyer

Author(s):Fact checked by:The recent trial indicates that the oral treatment gildeuretinol reduces GA lesion growth rates, as well as achieving better BCVA scores.
Study Supports Adalimumab Biosimilar Interchangeability for Patients with Psoriasis

6 days ago | hcplive.com | Tim Smith

New findings support adalimumab biosimilar interchangeability and the practice of non-medical switches between such biosimilars for patients with psoriasis, with the most commonly registered treatment discontinuation reason being a loss of effect.1These findings represent the conclusion of research conducted by such investigators as Ole Krogh-Jensen, from the Department of Dermatology and Allergy at Copenhagen University Hospital in Denmark.
Aquatic Exercise, Resistance Training Most Beneficial for Reducing Fibromyalgia Pain

6 days ago | hcplive.com | Victoria Johnson

Aquatic exercise for the short term, and then resistance training for the long term, were the most effective therapeutic exercises (TE) for reducing pain intensity in women with fibromyalgia, according to a new network meta-analysis (NMA).1“To date, we have not found any publications that compares all TE approaches with each other for the treatment of pain in fibromyalgia.